Selenic Acid

Summary

Selenic Acid (CHEMBL2097002) is a phase-3 clinical-stage small molecule.

At a glance

• Status: Max clinical phase 3 (not approved)
• Modality: Small molecule
• Chemistry: 144.98 Da · H2O4Se

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2097002
Name	Selenic Acid
Type	Small molecule
Max phase	3
FDA approved	no
PubChem CID	1089
ChEBI	CHEBI:18170
Molecular formula	H2O4Se
Molecular weight	144.98
InChIKey	QYHFIVBSNOWOCQ-UHFFFAOYSA-N

SMILES: O[Se](=O)(=O)O

IUPAC name: selenic acid

Also known as: Selenate, selenate

Parent form; salt/anhydrous children: CHEMBL114503

Patent coverage: 5,099 distinct patent families (10,060 SureChEMBL compound mentions), from 2 matched compound structure(s). One matched structure accounts for 9,923 (99%) of the total. Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).